Literature DB >> 16580818

Attention for movement production: Abnormal profiles in schizophrenia.

Yvonne Nathalie Delevoye-Turrell, Pierre Thomas, Anne Giersch.   

Abstract

Entities:  

Mesh：

Year:  2006        PMID： 16580818     DOI： 10.1016/j.schres.2006.02.013

Source DB:  PubMed          Journal:  Schizophr Res        ISSN： 0920-9964            Impact factor:   4.939


× No keyword cloud information.
  7 in total

1.  Extended visual simultaneity thresholds in patients with schizophrenia.

Authors:  Anne Giersch; Laurence Lalanne; Caroline Corves; Janina Seubert; Zhuanghua Shi; Jack Foucher; Mark A Elliott
Journal:  Schizophr Bull       Date:  2008-03-21       Impact factor: 9.306

2.  Eye movements during natural actions in patients with schizophrenia.

Authors:  Céline Delerue; Mary Hayhoe; Muriel Boucart
Journal:  J Psychiatry Neurosci       Date:  2013-09       Impact factor: 6.186

3.  Motor Consciousness during Intention-Based and Stimulus-Based Actions: Modulating Attention Resources through Mindfulness Meditation.

Authors:  Yvonne Nathalie Delevoye-Turrell; Claudie Bobineau
Journal:  Front Psychol       Date:  2012-09-11

4.  Impaired attentional modulation of sensorimotor control and cortical excitability in schizophrenia.

Authors:  Loïc Carment; Lucile Dupin; Laura Guedj; Maxime Térémetz; Marie-Odile Krebs; Macarena Cuenca; Marc A Maier; Isabelle Amado; Påvel G Lindberg
Journal:  Brain       Date:  2019-07-01       Impact factor: 13.501

5.  Combined visual and motor disorganization in patients with schizophrenia.

Authors:  Anne Giersch; Hélène Wilquin; Rémi L Capa; Yvonne N Delevoye-Turrell
Journal:  Front Psychol       Date:  2013-09-18

6.  Imagined motor action and eye movements in schizophrenia.

Authors:  Céline Delerue; Muriel Boucart
Journal:  Front Psychol       Date:  2013-07-12

7.  Implicit Timing as the Missing Link between Neurobiological and Self Disorders in Schizophrenia?

Authors:  Anne Giersch; Laurence Lalanne; Philippe Isope
Journal:  Front Hum Neurosci       Date:  2016-06-20       Impact factor: 3.169
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.